Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016


Sreih A. G. , Alibaz-Oner F. , Kermani T. A. , Aydin S. Z. , Cronholm P. F. , Davis T., ...Daha Fazla

JOURNAL OF RHEUMATOLOGY, cilt.44, ss.1933-1937, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 44 Konu: 12
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3899/jrheum.161467
  • Dergi Adı: JOURNAL OF RHEUMATOLOGY
  • Sayfa Sayıları: ss.1933-1937

Özet

Objective. Among the challenges in conducting clinical trials in large-vessel vasculitis (LVV), including both giant cell arteritis (GCA) and Takayasu arteritis (TA), is the lack of standardized and meaningful outcome measures. The Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group initiated an international effort to develop and validate data-driven outcome tools for clinical investigation in LVV.